U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07353840) titled 'T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR' on Jan. 12.
Brief Summary: This study is a multicenter, two-arm, prospective clinical trial, comprising two groups: the observation group and the autologous hematopoietic stem cell transplantation group (Auto-HSCT). It aims to evaluate the efficacy and safety of Auto-HSCT and observation in the treatment of peripheral T-cell lymphoma that has achieved complete response (CR) after first-line therapy. During the screening/baseline period, informed consent will be obtained, and inclusion/exclusion criteria will be verified. Group assignment (Observation vs. ...